company background image
ALNA.Q logo

Allena Pharmaceuticals OTCPK:ALNA.Q Stock Report

Last Price

US$0.0009

Market Cap

US$109.9k

7D

350.0%

1Y

-99.2%

Updated

30 May, 2023

Data

Company Financials

Allena Pharmaceuticals, Inc.

OTCPK:ALNA.Q Stock Report

Market Cap: US$109.9k

ALNA.Q Stock Overview

Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States.

ALNA.Q fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Allena Pharmaceuticals, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Allena Pharmaceuticals
Historical stock prices
Current Share PriceUS$0.0009
52 Week HighUS$0.44
52 Week LowUS$0.000001
Beta1.51
11 Month Change800.00%
3 Month Change12.50%
1 Year Change-99.24%
33 Year Change-99.97%
5 Year Change-99.99%
Change since IPO-99.99%

Recent News & Updates

Recent updates

First two cohorts enrolled in Allena's phase 2a trial of gout & kidney disease treatment

Jul 19

Allena Pharma reschedules special meeting to approve reverse stock split, shares fall

Jul 05

Allena Pharmaceuticals: A Double [Or More] Or Kaput In The Next 90 Days

Jan 08

Should You Review Recent Insider Transactions At Allena Pharmaceuticals, Inc. (NASDAQ:ALNA)?

Dec 29
Should You Review Recent Insider Transactions At Allena Pharmaceuticals, Inc. (NASDAQ:ALNA)?

Allena Pharmaceuticals announces $10M bought deal

Dec 01

Allena Pharma's ALLN-346 shows encouraging action in early-stage study

Nov 30

Allena Pharmaceuticals (ALNA) Investor Presentation - Slideshow

Nov 11

Allena Pharmaceuticals EPS misses by $0.01

Nov 09

Shareholder Returns

ALNA.QUS BiotechsUS Market
7D350.0%-0.4%-1.2%
1Y-99.2%20.1%30.6%

Return vs Industry: ALNA.Q underperformed the US Biotechs industry which returned -3.5% over the past year.

Return vs Market: ALNA.Q underperformed the US Market which returned 15.2% over the past year.

Price Volatility

Is ALNA.Q's price volatile compared to industry and market?
ALNA.Q volatility
ALNA.Q Average Weekly Movement349.4%
Biotechs Industry Average Movement9.6%
Market Average Movement6.0%
10% most volatile stocks in US Market14.9%
10% least volatile stocks in US Market2.9%

Stable Share Price: ALNA.Q's share price has been volatile over the past 3 months.

Volatility Over Time: ALNA.Q's weekly volatility has increased from 187% to 349% over the past year.

About the Company

FoundedEmployeesCEOWebsite
201112n/awww.allenapharma.com

Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts.

Allena Pharmaceuticals, Inc. Fundamentals Summary

How do Allena Pharmaceuticals's earnings and revenue compare to its market cap?
ALNA.Q fundamental statistics
Market capUS$109.87k
Earnings (TTM)-US$43.30m
Revenue (TTM)n/a

0.0x

P/S Ratio

0.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ALNA.Q income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$43.30m
Earnings-US$43.30m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.35
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio131.1%

How did ALNA.Q perform over the long term?

See historical performance and comparison